我院静脉药物配置中心不合理医嘱情况分析
Analysis of Unreasonable Medical Prescription in the Pharmacy Intravenous Admixture Service of Our Hospital
摘要: 目的:通过分析2022年我院静脉药物配置中心(Pharmacy Intravenous Admixture Service, PIVAS)在审核处方中所发现的不合理医嘱,为促进临床的静脉药物的合理用药提供数据与依据。方法:选择2022年我院静脉药物配置中心在审核医嘱中所发现的不合理医嘱305条(共408,184条医嘱),分析数据后进行讨论。结果:通过数据分析得出我院静脉药物不合理医嘱的类别有:药物剂量不适宜,终浓度不适宜,配伍禁忌,溶媒选择不当,重复用药以及其他原因的不规范医嘱。结论:我院静脉用药医嘱中存有一部分不合理医嘱,通过对不合理医嘱的原因分析,为指导临床合理用药提供依据。减少了临床用药不良事件的发生,保障了患者的用药安全。
Abstract: Objective: To provide data and basis for promoting the rational use of intravenous drugs in clinical practice, irrational medical instructions found in pharmacy intravenous admixture service (PIVAS) of our hospital were analyzed in 2022. Methods: 305 unreasonable medical orders (408,184 orders in total) found in the review of medical orders by pharmacy intravenous admixture service of our hospital in 2022 were selected, and the data were analyzed and discussed. Results: According to the data analysis, the categories of unreasonable medical orders of intravenous drugs in our hospital included inappropriate drug dosage, inappropriate final concentration, incompatibility, improper choice of solvent, repeated use of drugs and other reasons of non-standard medical orders. Conclusion: There are some unreasonable medical orders for intravenous drug use in our hospital. Through analyzing the causes of unreasonable medical orders, it can provide the basis for guiding clinical rational drug use. The occurrence of clinical adverse drug events is reduced, and the drug safety of patients is guaranteed.
文章引用:张家音, 李萌, 陈嘉升. 我院静脉药物配置中心不合理医嘱情况分析[J]. 药物资讯, 2023, 12(3): 196-201. https://doi.org/10.12677/PI.2023.123024

参考文献

[1] 卫办医政发[2010] 62号. 静脉用药集中调配质量管理规范[S]. 北京: 卫生部办公厅, 2010.
[2] 吴永佩, 焦雅辉. 临床静脉用药调配与使用指南[M]. 北京: 人民卫生出版社, 2010: 393.
[3] 刘全芳, 张鹰庆, 苏秀玲. 我院静脉药物配置中心不合理用药医嘱分析[J]. 海峡药学, 2021, 33(7): 187-189.
[4] 江宁. 静脉药物配置中心常见用药医嘱不合理用药分析[J]. 临床合理用药杂志, 2022, 15(5): 159-161. [Google Scholar] [CrossRef
[5] 陈济煜, 李君, 雷晓妹. 我院静脉配置中心不合理医嘱情况分析[J]. 中国当代医药, 2020, 27(15): 203-206.
[6] 陈静, 董艳莉, 任华成. 某院静脉用药配置中心不合理医嘱分析及干预[J]. 中国合理用药探索, 2020, 17(6): 20-24.
[7] 陈淑芳. 丙氨酰谷氨酰胺注射液临床应用合理性分析[J]. 临床合理用药杂志, 2022, 15(25): 160-163. [Google Scholar] [CrossRef
[8] 何苗苗, 谢六生, 刘光斌, 王艳. 临床药师对肿瘤化疗患者医嘱点评分析[J]. 甘肃科技纵横, 2022, 51(1): 78-82+85.
[9] 张燕伟, 王美华, 刘海燕, 杨亚彬, 李婷婷. 滇南某三甲综合医院2020年92例万古霉素临床应用分析[J]. 中国当代医药, 2023, 30(2): 148-152.
[10] 杨惠, 陈泽莲, 苏兰, 徐萍蓉, 李文斌, 刘屹. 多烯磷脂酰胆碱注射液配伍禁忌的文献分析[J]. 中国药师, 2017, 20(6): 1104-1105+1122.